首页> 外文期刊>Orphanet journal of rare diseases >Adult-onset Alexander disease, associated with a mutation in an alternative GFAP transcript, may be phenotypically modulated by a non-neutral HDAC6 variant
【24h】

Adult-onset Alexander disease, associated with a mutation in an alternative GFAP transcript, may be phenotypically modulated by a non-neutral HDAC6 variant

机译:与非GFAP转录本中的突变相关的成年亚历山大疾病可能由非中性HDAC6变体表型调节

获取原文
           

摘要

Background We studied a family including two half-siblings, sharing the same mother, affected by slowly progressive, adult-onset neurological syndromes. In spite of the diversity of the clinical features, characterized by a mild movement disorder with cognitive impairment in the elder patient, and severe motor-neuron disease (MND) in her half-brother, the brain Magnetic Resonance Imaging (MRI) features were compatible with adult-onset Alexander’s disease (AOAD), suggesting different expression of the same, genetically determined, condition. Methods Since mutations in the alpha isoform of glial fibrillary acidic protein, GFAP-α, the only cause so far known of AOAD, were excluded, we applied exome Next Generation Sequencing (NGS) to identify gene variants, which were then functionally validated by molecular characterization of recombinant and patient-derived cells. Results Exome-NGS revealed a mutation in a previously neglected GFAP isoform, GFAP-?, which disrupts the GFAP-associated filamentous cytoskeletal meshwork of astrocytoma cells. To shed light on the different clinical features in the two patients, we sought for variants in other genes. The male patient had a mutation, absent in his half-sister, in X-linked histone deacetylase 6, a candidate MND susceptibility gene. Conclusions Exome-NGS is an unbiased approach that not only helps identify new disease genes, but may also contribute to elucidate phenotypic expression.
机译:背景我们研究了一个家庭,该家庭包括两个同父异母的兄弟姐妹,他们共享同一个母亲,并受到缓慢进展的成人发病神经系统综合症的影响。尽管临床特征多种多样,其特征是老年患者患有轻度运动障碍并伴有认知障碍,而其同父异母兄弟则患有严重的运动神经元疾病(MND),但脑磁共振成像(MRI)的特征却是兼容的患有成人性亚历山大疾病(AOAD)的患者,提示在相同的遗传条件下病情会有所不同。方法由于排除了迄今为止已知的AOAD的唯一原因-神经胶质纤维酸性蛋白GFAP-α的突变,我们应用外显子组下一代测序(NGS)鉴定基因变体,然后通过分子功能验证重组和患者来源细胞的表征。结果Exome-NGS揭示了先前被忽略的GFAP亚型GFAP-α的突变,该突变破坏了GFAP相关的星形细胞瘤细胞丝状细胞骨架网状结构。为了阐明两名患者的不同临床特征,我们寻找其他基因的变异体。男性患者的半姐妹中没有X连锁组蛋白脱乙酰基酶6(MND候选基因)突变。结论Exome-NGS是一种无偏见的方法,不仅有助于鉴定新的疾病基因,而且可能有助于阐明表型的表达。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号